人脂肪组织来源干细胞在心脏疾病治疗中的应用

目的:综述人脂肪组织来源干细胞的生物学特性及其在缺血性心脏病中的应用,分析不足,并在此基础上提出未来研究要解决的问题,以期为临床治疗提供依据。资料来源:应用计算机检索Blackwell、Elsevier、Pubmed数据库1980/2007期间脂肪源性干细胞与缺血性心脏病方面的文献,检索词为“bone mesenchymal stem cells,adipose derived stemcells,cardiomyocytes,ischemic heart disease”等。应用计算机检索中国期刊全文数据库1980/2007期间相关文献,检索词为“骨髓间充质干细胞,脂肪组织来源的干细胞,心肌细胞,缺血性心脏病”等。并手工查阅相关书籍。资料选择:对资料进行初步选择:①脂肪组织来源干细胞的生物学特性。②脂肪组织来源干细胞治疗缺血性心脏病。排除重复文献。资料提炼:共搜集到相关文章57篇,删除内容重复及与本文主题关系较远的文章,剩余41篇作为综述参考。资料综合:脂肪组织来源干细胞与同样起源于中胚层的骨髓基质细胞不仅具有非常相似的生物学特性,而且在细胞表面标志谱的表达方面也非常相近。并且脂肪组织来源广泛,取材方便,可获得的基质细胞数量大,易于培养扩增。有研究发现,脂肪组织来源干细胞体外培养不需要任何诱导便能分化成具有自律性的心肌细胞,使得脂肪组织来源干细胞治疗缺血性心脏病成为可能。结论:脂肪组织来源干细胞在取材和增殖方面较骨髓间充质干细胞有优势;脂肪组织来源干细胞能较好的诱导为心肌细胞,将为缺血性心脏病的治疗提供更广阔的前景。     

HPLC法测定血浆中六亚甲基二乙酰胺浓度

ＨＰＬＣ法测定血浆中六亚甲基二乙酰胺浓度赵玉喜，何晓英，蒋淼，谢景文，谢廷泉，任礼勤（兰州军区总医院药材科，兰州７３００５０）六亚甲基二乙酰胺（ｈｅｘａｍｅｔｈｙｌｅｎｅｂｉｓａｃｅｔａｍｉｄｅ，ＨＭＢＡ）是结构上与二甲基亚砜（ＤＭｓＯ）和Ｎ－甲基甲...     

CR3的Ⅰ结构域的克隆和在CHO细胞中的表达及配体结合特性的研究

研究白细胞整体合素ＣＲ３α亚基的Ⅰ结构域在配体结合中的作用。方法克隆ＣＤ１１ｂ的Ⅰ结构域，用重叠ＰＣＲ的方法将其与信号肽ＤＮＡ连接，克隆到表达载体ＰＥＥ６ＨＣＭＶ．ＧＳ，转化ＣＨＯ－Ｋ１细胞。表达的Ⅰ－结构域经ＳＰ－Ｓｅｐｈａｒｏｓｅ和ｍｏｎｏ－Ｓ柱纯化后，与Ｃ３ｂｉ进行配体结构实验。结果用ＳＤＳ－ＰＡＧＥ测得重组的Ⅰ结构域分子量为２９ＫＤ。重组的Ⅰ结构域可以与Ｃ３ｂｉ结合，Ｓｃａｔｃｈａｒｄ分析     

需要与可能——向颅面外科进军

“需要”是指患者的需要、临床工作的需要,“可能”是指口腔颌面外科医师可能开展颅面外科手术吗？1984／2008,我们共完成颅面外科手术1000余例,是国内开展颅面外科手术早、病例最多的一所口腔医院．我们与西京医院神经外科、眼科、耳鼻喉科共同协作并开展新手术,治疗了各专科难以治疗的患者,取得了很好的效果．     

用改良消减法克隆类风湿性关节炎滑膜细胞中的高表达基因

0　引言　在类风湿性关节炎 (rheumatoid arthritis,RA)中 ,关节内滑膜细胞 (fibroblast- like synovial cells,FL S)的过度增生是造成关节软骨破坏和关节畸形的关键环节 ,为了研究滑膜细胞发生增殖的机制 ,我们采用赵忠良等人设计的改良消减杂交法[1 ] ,并以骨性关节炎 (osteoarthritis,OA)滑膜细胞为对照筛选 RA滑膜细胞中的高表达基因 .1　方法　将 RA滑膜细胞和 OA滑膜细胞分别设定为实验组和扣除组 ,用扣除组的 c DNAs杂交扣除掉实验组中与前者相同的 c DNAs,得到的就是目的产物 :实验组中高拷贝数的或独有的 c DNAs,也就是 …     

体外培养脂肪组织来源干细胞与胶原/壳聚糖复合支架的亲和性

目的：制备适合脂肪组织来源的干细胞生长的支架,观察复合支架各组成的体积比率与细胞培养的亲和性. 方法：实验于2006-09/2007-01在大连理工大学干细胞与组织工程研发中心完成.①实验方法：将3.55 g/L Ⅰ型胶原和20 g/L壳聚糖分别以9∶1,7∶3,5∶5,3∶7,1∶9的体积比混合冻干,碳化二亚胺/N-羟基琥珀酰亚胺交联后再次冻干并进行分析.②实验评估：扫描电镜观察不同材料交联前后的微观结构;IPP软件分析计算支架的平均孔径;测量支架的吸水性和孔隙率;通过胶原酶检测支架的体外生物可降解性;扫描电镜和苏木精-伊红染色观察脂肪组织来源的干细胞在复合支架上的生长情况. 结果：①交联前后的微观结构：冻干后的各种支架材料呈白色,表面粗糙,材料内部呈海绵状多孔隙结构,其中以胶原/壳聚糖体积比为9∶1的复合支架最为疏松,1∶9的支架最致密.扫描电镜下支架的胶原含量越高,支架内的胶原丝越多,支架的孔与孔之间相互连通构成了通孔.交联前后支架的形态结构无明显改变.②支架的平均孔径∶交联后体积比为9∶1,7∶3和5∶5的复合支架孔径50～200 μm,可用于细胞的三维培养.③支架的吸水性和孔隙率∶体积比为5∶5的复合支架的吸水性和含水量最高,而7∶3次之;多孔支架在水中未发生明显的溶胀现象;支架的孔隙率均在90%以上.④支架的体外生物可降解性：未交联的支架随着胶原含量的减少,支架的降解速率增加.而交联后随着胶原含量的减少,降解速率减慢,交联后的复合支架降解速度较未交联慢.⑤脂肪组织来源的干细胞在复合支架上的生长情况：脂肪组织来源的干细胞在支架上培养5 d后扫描电镜观察细胞在7∶3的支架上爬行生长并融合成片,苏木精-伊红染色观察支架孔内及表面出现大量的细胞团,并融合成片状,而5∶5支架上黏附生长的细胞较少. 结论：结合支架的孔径、吸水性、孔隙率、体外生物可降解性和细胞与支架的生物相容性,可知体积比为7∶3的复合支架对脂肪组织来源的干细胞的亲和性较好,适于脂肪组织来源的干细胞的三维培养.     

Evaluation of in vitro human gingival fibroblast seeding on acellular dermal matrix

The acellular dermal matrix (ADM) was introduced in periodontology as a substitute for the autogenous grafts, which became restricted because of the limited source of donor's tissue. The aim of this study was to investigate, in vitro, the distribution, proliferation and viability of human gingival fibroblasts seeded onto ADM. ADM was seeded with human gingival fibroblasts for up to 21 days. The following parameters were evaluated: cell distribution, proliferation and viability. Results revealed that, at day 7, fibroblasts were adherent and spread on ADM surface, and were unevenly distributed, forming a discontinuous single cell layer; at day 14, a confluent fibroblastic monolayer lining ADM surface was noticed. At day 21, the cell monolayer exhibited a reduction in cell density. At 7 days, about to 90% of adherent cells on ADM surface were cycling while at 14 and 21 days this proportion was significantly reduced. A high proportion of viable cell was detected on AMD surface both on 14 and 21 days. The results suggest that fibroblast seeding onto ADM for 14 days can allow good conditions for cell adhesion and spreading on the matrix; however, migration inside the matrix was limited.     

Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use

OBJECTIVES: To evaluate the antibiotic susceptibility of Streptococcus pneumoniae isolates obtained from the blood and cerebrospinal fluid of children with meningitis. To describe and compare the clinical and microbiological characteristics, treatment, and outcome of children with meningitis caused by S pneumoniae based on antimicrobial susceptibility of isolates and the administration of dexamethasone. DESIGN AND PATIENTS: Children with pneumococcal meningitis were identified from among a group of patients with systemic infections caused by S pneumoniae who were enrolled prospectively in the United States Pediatric Multicenter Pneumococcal Surveillance Study at eight children's hospitals in the United States. From September 1, 1993 to August 31, 1996, 180 children with 181 episodes of pneumococcal meningitis were identified and data were collected by retrospective chart review. OUTCOME: Clinical and laboratory characteristics were assessed. All pneumococcal isolates were serotyped and antibiotic susceptibilities for penicillin and ceftriaxone were determined. Clinical presentation, hospital course, and outcome parameters at discharge were compared between children infected with penicillin-susceptible isolates and those with nonsusceptible isolates and for children who did and did not receive dexamethasone. RESULTS: Fourteen (7.7%) of 180 children died; none of the fatalities were because of a documented failure of treatment caused by a resistant strain. Only 1 child, who had mastoiditis and a lymphangioma, experienced a bacteriologic failure with a penicillin-resistant (minimum inhibitory concentration = 2 microgram/mL) organism. Of the 166 surviving children, 41 (25%) developed neurologic sequelae (motor deficits) and 48 (32%) of 151 children had unilateral (n = 26) or bilateral (n = 22) moderate to severe hearing loss at discharge. Overall, 12.7% and 6.6% of the pneumococcal isolates were intermediate and resistant to penicillin and 4.4% and 2.8% were intermediate and resistant to ceftriaxone, respectively. Clinical presentation, cerebrospinal fluid indices on admission, and hospital course, morbidity, and mortality rates were similar for patients infected with penicillin- or ceftriaxone-susceptible versus nonsusceptible organisms. However, the relatively small numbers of nonsusceptible isolates and the inclusion of vancomycin in the treatment regimen for the majority of the patients limit the power of this study to detect significant differences in outcome between patients infected with susceptible and nonsusceptible isolates. Nonetheless, our results show that the nonsusceptible organisms do not seem to be intrinsically more virulent. Forty children (22%) received dexamethasone (>/=8 doses) initiated before or within 1 hour after the first dose of antibiotics. The incidence of any moderate or severe hearing loss was significantly higher in the dexamethasone group (46%) compared with children not receiving any dexamethasone (23%). The incidence of any neurologic deficits, including hearing loss, also was significantly higher in the dexamethasone group (55% vs 33%). However, children in the dexamethasone group more frequently required intubation and mechanical ventilation and had lower initial concentration of glucose in the cerebrospinal fluid than children who did not receive any dexamethasone. When we controlled for the confounding factor, severity of illness (intubation), the incidence of any deafness and of any neurologic sequelae, including deafness, were no longer significantly different between children who did or did not receive dexamethasone. CONCLUSIONS: Children with pneumococcal meningitis caused by penicillin- or ceftriaxone-nonsusceptible organisms and those infected by susceptible strains had similar clinical presentation and outcome. The use of dexamethasone was not associated with a beneficial effect in this retrospective and nonrandomized study. (ABSTRACT TRUNCATED)